Nanoscope Therapeutics

[Not Yet Scheduled]
Clinical Stage Occular Gene Therapy Startup
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Texas
Company HQ Country:
United States
Year Founded:
2017
Main Therapeutic Focus:
Lead Product in Development:
MCO-010
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
2
Speaker
photo
Co-Founder & CEO
Nanoscope Therapeutics, Inc.